Correlation Between Vertiv Holdings and Mydecine Innovations

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vertiv Holdings and Mydecine Innovations at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertiv Holdings and Mydecine Innovations into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertiv Holdings Co and Mydecine Innovations Group, you can compare the effects of market volatilities on Vertiv Holdings and Mydecine Innovations and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertiv Holdings with a short position of Mydecine Innovations. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertiv Holdings and Mydecine Innovations.

Diversification Opportunities for Vertiv Holdings and Mydecine Innovations

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Vertiv and Mydecine is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Vertiv Holdings Co and Mydecine Innovations Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mydecine Innovations and Vertiv Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertiv Holdings Co are associated (or correlated) with Mydecine Innovations. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mydecine Innovations has no effect on the direction of Vertiv Holdings i.e., Vertiv Holdings and Mydecine Innovations go up and down completely randomly.

Pair Corralation between Vertiv Holdings and Mydecine Innovations

Considering the 90-day investment horizon Vertiv Holdings Co is expected to under-perform the Mydecine Innovations. But the stock apears to be less risky and, when comparing its historical volatility, Vertiv Holdings Co is 12.43 times less risky than Mydecine Innovations. The stock trades about -0.19 of its potential returns per unit of risk. The Mydecine Innovations Group is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  0.50  in Mydecine Innovations Group on September 24, 2024 and sell it today you would lose (0.10) from holding Mydecine Innovations Group or give up 20.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Vertiv Holdings Co  vs.  Mydecine Innovations Group

 Performance 
       Timeline  
Vertiv Holdings 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Vertiv Holdings Co are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Vertiv Holdings unveiled solid returns over the last few months and may actually be approaching a breakup point.
Mydecine Innovations 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.

Vertiv Holdings and Mydecine Innovations Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vertiv Holdings and Mydecine Innovations

The main advantage of trading using opposite Vertiv Holdings and Mydecine Innovations positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertiv Holdings position performs unexpectedly, Mydecine Innovations can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mydecine Innovations will offset losses from the drop in Mydecine Innovations' long position.
The idea behind Vertiv Holdings Co and Mydecine Innovations Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm